The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial.
 
Naomi B. Haas
Stock and Other Ownership Interests - TetraLogic Pharmaceuticals (I)
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck
Expert Testimony - Lilly (I)
 
Judith Manola
No Relationships to Disclose
 
Robert G. Uzzo
Honoraria - GlaxoSmithKline; Johnson & Johnson
Consulting or Advisory Role - Myriad Genetics
Speakers' Bureau - Janssen Oncology
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; C-Cam; Genentech; GlaxoSmithKline; Lilly; Merck; Neostem; Novartis; Novartis; Pfizer; X4 Pharma
 
George Wilding
No Relationships to Disclose
 
Michael Pins
No Relationships to Disclose
 
Michael A. S. Jewett
Employment - Impact Genetics (I)
Leadership - Impact Genetics (I)
Stock and Other Ownership Interests - Impact Genetics (I)
Honoraria - Janssen Oncology; Myriad Genetics; Novartis; Pfizer
Consulting or Advisory Role - Theralase
Research Funding - Olympus Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Christopher J. Kane
No Relationships to Disclose
 
David Cella
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - AVEO; GlaxoSmithKline; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline
 
Lynne I. Wagner
No Relationships to Disclose
 
Bob Coomes
No Relationships to Disclose
 
Christopher G. Wood
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Argos Therapeutics; Boehringer Ingelheim; GlaxoSmithKline; Ono Pharmaceutical; Pfizer
Travel, Accommodations, Expenses - Argos Therapeutics
 
Janice P. Dutcher
No Relationships to Disclose
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo
Consulting or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Lilly; Merck; Momenta Pharmaceuticals; Novartis; Oncoceutics; Sanofi; Viralytics; ZIOPHARM Oncology
Research Funding - Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi
 
Robert S. DiPaola
No Relationships to Disclose